Christine L.
- Country
- France
- Department
- Dermatology pediatric department
Research Overview
- Efficacy and Safety of Alpelisib in Pediatric and Adult Patients with PIK3CA-Mutated Lymphatic Malformations: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Ruxolitinib Cream in Pediatric Patients Aged 6 to <12 Years with Nonsegmental Vitiligo: A Phase 3 Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 9 of 87 partner sites.
Specializations
Vascular Medicine
The investigator specializes in the treatment of lymphatic malformations, with particular emphasis on cases involving genetic mutations.
- Vascular Anomalies
- Lymphatic System Disorders
- Genetic Vascular Conditions
Expertise includes evaluating therapeutic responses in patients with PIK3CA-associated lymphatic disorders.
Genetic Medicine
Focus on understanding and treating conditions related to PIK3CA pathway mutations and their manifestations in vascular tissues.
- Mutation-Specific Therapies
- Genetic Pathway Analysis
- Precision Medicine Approaches
Special interest in age-specific treatment responses across different patient populations.
Clinical Assessment
Expertise in radiological evaluation of vascular anomalies and treatment response assessment.
- Treatment Response Monitoring
- Long-term Outcome Assessment
- Age-Specific Clinical Protocols
Experience in both adult and pediatric patient populations with vascular disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.